John L. Jefferies, MD, MPH, is the new governor-elect of the Tennessee Chapter of the American College of Cardiology (TNACC) and will become governor of the organization in 2021. He believes these new positions will allow him to help Memphis and the University of Tennessee Health Science Center play leading roles in improving cardiac care… Read More
Memphis community advocates and faculty from UTHSC came together at the University of Tennessee Health Science Center for a symposium to discuss drug abuse and addiction in Tennessee and its negative impact on overall health outcomes. The Symposium on Drug Abuse and Addiction, the first in what is hoped will be a series of symposiums… Read More
For the second year in a row, Paul Klimo, Jr. MD, MPH, associate professor in the Department of Neurosurgery at the University of Tennessee Health Science Center, was awarded the Pediatrics Paper of the Year by the Congress of Neurological Surgeons (CNS) during the CNS annual meeting in San Francisco, California. The paper, “The Preventable Shunt… Read More
Fredrick Boop, MD, co-director of the Neuroscience Institute at the University of Tennessee Health Science Center, was recently named president-elect of the International Society for Pediatric Neurosurgery (ISPN). Dr. Boop is the professor and chairman of the Department of Neurosurgery at UTHSC, co-director of the Neurosurgical Intensive Care Unit at Le Bonheur Children’s Hospital, and… Read More
Duane Miller, PhD, retired from the College of Pharmacy at the University of Tennessee Health Science Center in 2015, but he still comes to work four days a week. Dr. Miller has made research his retirement, because how can you sit at home when you’ve spent your life ferreting out what could lead to next-generation… Read More
The College of Medicine at the University of Tennessee Health Science Center is hosting the first in a series of Mini-Symposiums on Drug Abuse and Addiction to bring together community practices and addiction science to better understand drug abuse and addiction in Tennessee and its impact on overall health outcomes. The first meeting will be… Read More
Patients with sickle cell disease will soon have a new treatment option to reduce pain crises caused by obstructed blood flow. The FDA has approved use of the drug crizanlizumab based on the results of a clinical trial led by Kenneth Ataga, MD, Plough Foundation Endowed Chair in Sickle Cell Disease and director of the… Read More
A new study by researchers at the University of Tennessee Health Science Center and the University of Iowa provides good news for patients with atrial fibrillation (AFib), or irregular heartbeat, who are at greater risk for stroke but cannot tolerate long-term anticoagulation therapy, the first-line treatment to prevent stroke. The study determined that an implanted… Read More
